Utility of cytokeratin 20 and Ki‐67 as markers of urothelial dysplasia
Authors:
- 5 May 2005
- journal article
- research article
- Published by Wiley in Pathology International
- Vol. 55 (5) , 248-254
Abstract
Reactive urothelial atypia (RUA) can be difficult to differentiate from dysplastic urothelium. The goal was to evaluate the efficacy of cytokeratin 20 (CK20), Ki‐67 and E‐cadherin (E‐Cad) in this regard. Fifty carcinoma in situ (CIS) cases, 50 non‐neoplastic urothelia (25 normal, 25 reactive urothelial atypia (RUA)) and 17 atypia of unknown significance (AUS) cases were evaluated. All cases were stained with monoclonal antibodies against Ki‐67, CK20 and E‐Cad. All (100%) normal urothelia showed normal staining patterns. In the CIS group, 86%, 82% and 20% of cases showed abnormal expression with CK20, Ki‐67 and E‐Cad, respectively. Both Ki‐67 and CK20 were positive in 68% of cases. In the RUA group, 96%, 72% and 100% of cases showed normal expression patterns with CK20, Ki‐67 and E‐Cad, respectively. Of 28% RUA cases with increased Ki‐67, none demonstrated abnormal CK20 or E‐Cad expression. In the AUS group, 47% demonstrated abnormal CK20 and increased Ki‐67 expression, suggestive of urothelial dysplasia/CIS, 29% were negative with both, suggestive of RUA, and the remaining 24% cases could not be resolved. In summary, abnormal CK20 is a useful adjunct to morphology for confirming dysplasia. Ki‐67 by itself is a less reliable marker of dysplasia. E‐Cad is not a useful marker in this setting.Keywords
This publication has 24 references indexed in Scilit:
- Mucin 7 and Cytokeratin 20 as New Diagnostic Urinary Markers for Bladder TumorJournal of Urology, 2003
- Mucin 7 and Cytokeratin 20 as New Diagnostic Urinary Markers for Bladder TumorJournal of Urology, 2003
- E-CADHERIN IMMUNOSTAINING OF BLADDER TRANSITIONAL CELL CARCINOMA, CARCINOMA IN SITU AND LYMPH NODE METASTASES WITH LONG-TERM FOLLOWUPJournal of Urology, 2001
- THE LIMITS OF BACILLUS CALMETTE-GUERIN FOR CARCINOMA IN SITU OF THE BLADDERJournal of Urology, 2001
- THE LIMITS OF BACILLUS CALMETTE-GUERIN FOR CARCINOMA IN SITU OF THE BLADDERJournal of Urology, 2001
- Immunophenotype of High-Grade Prostatic Adenocarcinoma and Urothelial CarcinomaLaboratory Investigation, 2000
- ALTERED gamma-CATENIN EXPRESSION CORRELATES WITH POOR SURVIVAL IN PATIENTS WITH BLADDER CANCERJournal of Urology, 1998
- Cytokeratin 20 as an objective marker of urothelial dysplasiaBritish Journal of Urology, 1996
- Loss of human E-cadherin (ECD) correlated with invasiveness of transitional cell cancer in the renal pelvis, ureter and urinary bladderCancer Letters, 1996
- Progression and survival in transitional cell bladder cancer: a comparison of established prognostic factors, S-phase fraction and DNA ploidyEuropean Journal of Cancer and Clinical Oncology, 1991